Afecta Pharmaceuticals Is An Early Clinical Stage Small Molecule Therapeutics Company Focused On Developing Precision Medicines To Treat Chronic Disorders And Cancers More Effectivelyafecta Has A Validatedproprietary Artificial Intelligence Disease Drug Targeting Platformpharmetrxa To Discover And Optimize Multi Target Drug Compounds And Formulate Them In Nanorxa Our Tissue Specific Drug Delivery Technologybacked By An Experienced Management Teamafecta Is Currently Advancing Afx 220Our Clinically Proven Lead Candidate That Effectively Treats The Disruptive Behaviors That Occur In Children And Adolescents With Several Neurodevelopmental Disorders Such As Autismad Hdand Othersplease Visit Our Website To Learn Moreregister To Access Our Executive Summaryand Receive Our Latest Updates
